Pathway analysis indicated that the DEGs were involved in multiple tumor-associated pathways, such as PI3K-Akt signaling, MAPK signaling, eGMP-PKG signaling, TNF signaling pathways, etc. (Fig. 7C, Table S4). The gene discussed is TNF; the disease is neoplasm.